Fri, April 14, 2023
Thu, April 13, 2023
Wed, April 12, 2023
Tue, April 11, 2023
Mon, April 10, 2023

Anupam Rama Maintained (VERA) at Buy with Decreased Target to $22 on, Apr 12th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-22-on-apr-12th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Anupam Rama of JP Morgan, Maintained "Vera Therapeutics, Inc." (VERA) at Buy with Decreased Target from $38 to $22 on, Apr 12th, 2023.

Anupam has made no other calls on VERA in the last 4 months.



There are 3 other peers that have a rating on VERA. Out of the 3 peers that are also analyzing VERA, 2 agree with Anupam's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Downgraded from Buy to Hold and Held Target at $8 on, Wednesday, January 4th, 2023
  • Maury Raycroft of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $6 on, Wednesday, January 4th, 2023


This is the rating of the analyst that currently disagrees with Anupam


  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $11 on, Wednesday, March 29th, 2023

Publication Contributing Sources